Appleton Partners Inc Ac Immune Sa Transaction History

Appleton Partners Inc

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 13, 2020	SELL	$4.56 - $8.78 $52,553 - $101,189	-11,525 Closed	0 $0
Q3 2019 Nov 04, 2019	SELL	$4.8 - $5.89 $18,408 - $22,588	-3,835 Reduced 24.97%	11,525 $57,000
Q2 2019 Jul 25, 2019	BUY	$4.72 - $5.88 $72,499 - $90,316	15,360 New	15,360 $85,000

28.6M

163K

37.6K

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $283M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

Get notified when there are updates to the investment portfolio of Appleton Partners Inc, based on Form 13F filings with the SEC.

Stay updated on Appleton Partners Inc with notifications on news.